**Market-implied odds heavily favor "No" at 94.3% because official surveillance shows no novel coronavirus exhibiting sustained global human-to-human transmission through mid-2026.** CDC data indicate COVID-19 infections declining or stable in most U.S. states, with emergency department visits at just 0.1% and an Rt estimate near 0.98, while WHO reports low, stable SARS-CoV-2 activity worldwide alongside minimal hospitalizations. Existing population immunity from prior infections and vaccinations further reduces escalation risk for known strains. Zoonotic candidates such as canine coronavirus remain under monitoring but lack evidence of efficient person-to-person spread. Realistic challenges include an unexpected spillover event or highly transmissible new variant emerging later in the year that alters transmissibility metrics before December 31.